The Immune System's Contribution to the Clinical Efficacy of EGFR Antagonist Treatment. (2017)

First Author: MacDonald F
Attributed to:  Use of EGF-R antagonists for the treatment of infections and tumour growth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2017.00575

PubMed Identifier: 28970798

Publication URI: http://europepmc.org/abstract/MED/28970798

Type: Journal Article/Review

Volume: 8

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812